University of Tokyo-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:University of Tokyo - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013601
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:28
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
The University of Tokyo (UTokyo) is a research university that offers undergraduate, graduate, professional and distance learning programs. The university offers courses in the field of science, agriculture, economics, law, medicine, engineering, pharmaceutical sciences, and others. It also gets funding from Japanese and foreign companies for various collaborative research projects. UTokyo partners with other institute to provide educational services. The university operates through its academic centers such as Asian Natural Environmental Science Center, Biotechnology Research Center, Center for Research and Development of Higher Education, Center for Spatial Information Science, Cryogenic Research Center, and others. UTokyo is headquartered in Bunkyo-Ku, Japan.

University of Tokyo – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
University of Tokyo, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
University of Tokyo, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
University of Tokyo, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
University of Tokyo, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
University of Tokyo, Medical Devices Deals, 2011 to YTD 2017 9
University of Tokyo, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
University of Tokyo, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Astellas Pharma Enters into Agreement with Institute of Medical Science, the University of Tokyo 11
IMSUT and Astellas Pharma Enter into Agreement 12
Sanofi Enters into Drug Discovery Agreement with University of Tokyo 13
University of Tokyo Enters Into Research Agreement With Astellas Pharma To Discover New Drugs For NTDs 14
Shimadzu Enters Into Research Agreement With University of Tokyo 15
TransGenic Enters Into Collaboration With Dainippon Sumitomo And The University of Tokyo 16
Licensing Agreements 17
TransGenic Enters into Licensing Agreement with University of Tokyo 17
BrightPath Biotherapeutics Enters into Licensing Agreement with University of Tokyo 18
Editas Medicine Enters into Licensing Agreement with Broad Institute, Harvard, MIT, Wageningen University, and University of Tokyo 19
Vedanta Biosciences Enters into Licensing Agreement with Riken, University of Tokyo, and Azabu University 21
Qiagen Enters into Licensing Agreement with University of Tokyo for SF3B1 22
University of Tokyo – Key Competitors 23
University of Tokyo – Key Employees 24
University of Tokyo – Locations And Subsidiaries 25
Head Office 25
Other Locations & Subsidiaries 25
Recent Developments 26
Product News 26
02/10/2016: Daiichi Sankyo Joint Development Product Designated Under “SAKIGAKE Designation System” 26
Product Approvals 27
Jul 11, 2017: Oncolytic Virus G47delta (DS-1647) designated as Orphan Drug under Orphan Drug/Medical Device Designation System 27
Appendix 28
Methodology 28
About GlobalData 28
Contact Us 28
Disclaimer 28

List of Tables
University of Tokyo, Pharmaceuticals & Healthcare, Key Facts 2
University of Tokyo, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
University of Tokyo, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
University of Tokyo, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
University of Tokyo, Deals By Therapy Area, 2011 to YTD 2017 8
University of Tokyo, Medical Devices Deals, 2011 to YTD 2017 9
University of Tokyo, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Astellas Pharma Enters into Agreement with Institute of Medical Science, the University of Tokyo 11
IMSUT and Astellas Pharma Enter into Agreement 12
Sanofi Enters into Drug Discovery Agreement with University of Tokyo 13
University of Tokyo Enters Into Research Agreement With Astellas Pharma To Discover New Drugs For NTDs 14
Shimadzu Enters Into Research Agreement With University of Tokyo 15
TransGenic Enters Into Collaboration With Dainippon Sumitomo And The University of Tokyo 16
TransGenic Enters into Licensing Agreement with University of Tokyo 17
BrightPath Biotherapeutics Enters into Licensing Agreement with University of Tokyo 18
Editas Medicine Enters into Licensing Agreement with Broad Institute, Harvard, MIT, Wageningen University, and University of Tokyo 19
Vedanta Biosciences Enters into Licensing Agreement with Riken, University of Tokyo, and Azabu University 21
Qiagen Enters into Licensing Agreement with University of Tokyo for SF3B1 22
University of Tokyo, Key Competitors 23
University of Tokyo, Key Employees 24
University of Tokyo, Subsidiaries 25

★海外企業調査レポート[University of Tokyo-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Benesse Holdings Inc (9783):企業の財務・戦略的SWOT分析
    Benesse Holdings Inc (9783) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • GRP Limited (GRPLTD):企業の財務・戦略的SWOT分析
    GRP Limited (GRPLTD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Stereotaxis Inc (STXS):医療機器:M&Aディール及び事業提携情報
    Summary Stereotaxis Inc (Stereotaxis) designs, manufactures and markets robotic systems and instruments for electrophysiologists for the treatment of cardiac arrhythmias. Its flagship product, Epoch solution is an advanced remote robotic navigation system for use in interventional lab for the treatm …
  • China National Offshore Oil Corp:石油・ガス:M&Aディール及び事業提携情報
    Summary China National Offshore Oil Corp (CNOOC) carries out exploration, development, and production of crude oil and natural gas. The company also offers engineering and technical services, including oilfield, offshore oil engineering, and professional services. It is also involved in the producti …
  • Transocean Ltd (RIG):石油・ガス:M&Aディール及び事業提携情報
    Summary Transocean Ltd (Transocean) is a provider of offshore contract drilling services to the oil and gas industry. The company specializes in the technically demanding regions of the global offshore drilling business with a particular focus on deepwater and harsh environment drilling services. Tr …
  • Filtration Group Corporation:企業の戦略的SWOT分析
    Filtration Group Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Jupiter Energy Ltd (JPR):企業の財務・戦略的SWOT分析
    Summary Jupiter Energy Ltd (Jupiter Energy) is an oil exploration and production company. The company carries out acquisition, exploration, production, and develops oil and natural gas properties. Jupiter Energy holds an exploration permit in the oil-rich Mangistau Basin in West Kazakhstan. It also …
  • Cytox Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Cytox Ltd (Cytox) is a prognostic and diagnostic service provider that develops neurodegenerative disorders services. The company offers development of tests to identify individuals at risk of cognitive decline, Alzheimer’s disease and other dementias and its blood tests are used to predict …
  • Bonheur ASA (BON):企業の財務・戦略的SWOT分析
    Summary Bonheur ASA (Bonheur) is an oil and gas investment service provider that offers investment services for various energy sectors. The company invests in renewable energy, cruise, shipping and offshore wind, offshore drilling, and other investments. It operates shipping vessels for transport an …
  • Galp Energia SGPS SA (GALP)-エネルギー分野:企業M&A・提携分析
    Summary Galp Energia SGPS S.A. (Galp Energia) is an integrated oil and natural gas company. It explores for, develops and produces crude oil and natural gas; refines crude oil and markets refined petroleum products. The company also imports, transports and distributes natural gas. It conducts the na …
  • University of California San Diego-医療機器分野:企業M&A・提携分析
    Summary University of California San Diego (UCSD), a subsidiary of University of California, is a public research university that offers education and research with a portfolio of undergraduate, graduate, postdoctoral and professional schools. It offers courses in various fields including arts and h …
  • Spicers Limited (SRS):企業の財務・戦略的SWOT分析
    Spicers Limited (SRS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Advanced Info Service PLC (ADVANC):企業の財務・戦略的SWOT分析
    Advanced Info Service PLC (ADVANC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Bank Hapoalim Bm:企業の戦略・SWOT・財務分析
    Bank Hapoalim Bm - Strategy, SWOT and Corporate Finance Report Summary Bank Hapoalim Bm - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Perenco Holdings:企業の戦略的SWOT分析
    Perenco Holdings - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Pierre & Vacances SA (VAC):企業の財務・戦略的SWOT分析
    Pierre & Vacances SA (VAC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Novatek (NVTK):企業の財務・戦略的SWOT分析
    Novatek (NVTK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Toshiba Corporation:企業の戦略・SWOT・財務分析
    Toshiba Corporation - Strategy, SWOT and Corporate Finance Report Summary Toshiba Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • The Boston Consulting Group:企業の戦略的SWOT分析
    The Boston Consulting Group - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Tiscali Group:企業の戦略・SWOT・財務分析
    Tiscali Group - Strategy, SWOT and Corporate Finance Report Summary Tiscali Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆